{"id":32256,"date":"2026-06-01T21:50:34","date_gmt":"2026-06-02T02:50:34","guid":{"rendered":"https:\/\/wholehealthchicago.com\/blog\/?p=32256"},"modified":"2026-06-01T21:50:38","modified_gmt":"2026-06-02T02:50:38","slug":"could-skinny-shots-cure-fibromyalgia","status":"publish","type":"post","link":"https:\/\/wholehealthchicago.com\/blog\/2026\/06\/01\/could-skinny-shots-cure-fibromyalgia","title":{"rendered":"COULD \u201cSKINNY SHOTS\u201d CURE FIBROMYALGIA?"},"content":{"rendered":"\n

The most well-known, so-called \u2018skinny shots\u2019 are semaglutide and tirzepatide. the GLP-1 inhibitors may be better known by their heavily advertised brand names Ozempic (semaglutide), Mounjaro (tirzepatide), and Zepbound (also tirzepatide). If it seems like \u2018everybody\u2019s on them,\u2019 you\u2019re right. Currently 18% of the U.S. population report having used a GLP-1 inhibitor at some time in their lives.<\/p>\n\n\n\n

If you\u2019ve not tried a GLP-1, the med works by balancing your blood sugar, slowing your digestion, and preventing you from feeling hunger. You literally forget to eat. You don\u2019t hear any background \u201cfood noise,\u201d no inner voice whispering (or screaming) \u201cfeed me that bag of potato chips, now!\u201d And then, slowly, steadily, at about a pound a week, you lose weight.<\/p>\n\n\n\n

With millions of patients on GLP-1 inhibitors, doctors began noticing side benefits. Many patients with autoimmune diseases like rheumatoid arthritis, inflammatory bowel disease, psoriasis, multiple sclerosis, and lupus remarked about feeling \u2018better.\u2019 Although the GLP-1\u2019s are not FDA approved for any of these conditions, many specialists are using them as \u2018add-on\u2019s\u2019 to conventional therapies. The science behind this is that at the heart of every autoimmune disease is an excess of an inflammatory molecule called a pro-inflammatory cytokine. These are literally \u201cpacked\u201d into fat cells. The levels of cytokines are measured by blood tests hsCRP (high sensitive C-Reactive Protein), TNF (Tumor Necrosis Factor), and IL-6 (interleukin-6). High levels of each trigger inflammation and pain.<\/p>\n\n\n\n

I have been working with fibromyalgia patients for thirty years. The condition affects about 4% of the population, 90% female, and to this day it is considered a \u201cclinical diagnosis\u201d based on listening to your patient and performing a physical exam. There are no \u201ctests\u201d for fibromyalgia. \u2018Fibro\u2019 is not an autoimmune disease but does seem to be an overreaction of the nervous system to \u2018pain signals.\u2019<\/p>\n\n\n\n

However, using the GLP-1 medications during the past two years has brought some extremely interesting results.<\/p>\n\n\n\n